Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$10.89K$10.89Kderived−56.0% vs Q4 2018 Net Income-$4.04M-$4.04MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived-$32,890N/M Operating Incomederived-$417,927N/M Operating Cash Flowderived-$308,721N/M Margins · derivedGross margin-301.9%−173.0 pt vs Q4 2018
Operating margin-3836.3%−2418.2 pt vs Q4 2018
Net margin-37045.3%
ended Dec 31, 2019 · filed Jul 1, 2021 · 548 d after period end